Objective To compare the therapeutic effects of subtotal parathyroidectomy (STPX) and total parathyroidectomy plus autologous transplantation in forearm (TPX-AT) on tertiary hyperparathyroidism (THPT) in patients with successful kidney transplantation. Method The patients with THPT after successful kidney transplantation and receiving STPX or TPX-AT from May 2018 to September 2021 were retrospectively reviewed. Their clinical data including age, sex, dialysis age, type of surgery, final pathological findings, preoperative biochemistry tests (serum calcium, iPTH, phosphorus, alkaline phosphatase, glomerular filtration rate, etc.) and postoperative iPTH at each following time were collected and analyzed. Result A total of 18 patients were included in this study, including 8 males and 10 females, with an average age of (45.56±3.46)years and an average dialysis time of (6.70±1.20)years. The patients were divided into STPX group and TPX-AT group, with 9 patients in each group. There were no significant differences in the preoperative values of mean serum calcium, phosphorus, ALP and iPTH between the two groups. At the first postoperative day, iPTH levels decreased to 98.88pg/ml and 39.39pg/ml in STPX group and TPX-AT group, respectively, but without statistical significance between the two groups (t=-1.423, P=0.181). The postoperative cure rates were 55.5% and 77.8% and the iPTH levels after the operation for 6 months were 105.52pg/ml and 151.07pg/ml in STPX group and TPX-AT group, respectively. The overall effective rate of the two groups was 61.1%; the effective rate was 55.5% in STPX group and was 66.7% in TPX-AT group. Conclusion The postoperative cure rate was higher in TPX-AT group than that in STPX group. However, the effective rates to THPT after the operation for 6 months were unsatisfactory in both groups. The iPTH level at the first postoperative day may be an indicator for prognosis of the THPT patients.
DONG Jie Yong
,
WANG Qiu-Yuan
,
CHENG Jing-Ning
,
ZHANG Ling
. Comparison of the outcomes of subtotal parathyroidectomy and total parathyroidectomy plus autotransplantation for tertiary hyperparathyroidism after kidney transplantation[J]. Chinese Journal of Blood Purification, 2023
, 22(05)
: 355
-358
.
DOI: 10.3969/j.issn.1671-4091.2023.05.008
[1] Portillo MR, Rodríguez-Ortiz ME. Secondary Hyperparthyroidism: Pathogenesis, Diagno-sis, Preventive and Therapeutic Strategies[J]. Rev Endocr Metab Disord, 2017,18(1):79-95.
[2] 张妍妍, 王培松, 王雪薇, 等. 三发性甲状旁腺功能亢进症诊治进展[J]. 中华内分泌外科杂志, 2020,14(1):83-86.
[3] Messa P, Alfieri CM. Secondary and Tertiary Hyperparathyroidism[J]. Front Horm Res, 2019,51:91-108.
[4] Palumbo VD, Palumbo VD, Damiano G, et al. Tertiary hyperparathyroidism: a review[J]. Clin Ter, 2021,172(3):241-246.
[5] Gioviale MC, Bellavia M, Damiano G, et al. Post-transplantation tertiary hyperparathy-roidism[J]. Ann Transplant, 2012,17(3):111-9.
[6] Lou I, Schneider DF, Leverson G, et al. Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation[J]. Surgery, 2016,159(1):172-9.
[7] Ozdemir FN, Afsar B, Akgul A, et al. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients[J]. Transplant Proc, 2006,38(2):480-2.
[8] Perrin P, Caillard S, Javier RM, et al. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation[J]. Am J Transplant, 2013,13(10):2653-63.
[9] Dulfer RR, Franssen G, Hesselink DA, et al. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism[J]. Br J Surg, 2017,104(7):804-813.
[10] Nicholson ML, Veitch PS, Feehally J. Parathyroidectomy in chronic renal failure: compar-ison of three operative strategies[J]. J R Coll Surg Edinb, 1996,41(6):382-7.
[11] Hiramitsu T, Hasegawa Y, Futamura K, et al. Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism[J]. Front Med (Lausanne), 2022,9:1007887.
[12] Choi HR, Aboueisha MA, Attia AS, et al. Outcomes of Subtotal Parathyroidectomy Versus Total Parathyroidectomy With Autotransplantation for Tertiary Hyperparathyroidism: Mul-ti-institutional Study[J]. Ann Surg, 2021,274(4):674-679.
[13] Hsieh TM, Sun CK, Chen YT, et al. Total parathyroidectomy versus subtotal parathyroid-ectomy in the treatment of tertiary hyperparathyroidism[J]. Am Surg, 2012,78(5):600-6.
[14] Zmijewski PV, Staloff JA, Wozniak MJ, et al. Subtotal Parathyroidectomy vs Total Para-thyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Dialysis Patients: Short- and Long-Term Outcomes[J]. J Am Coll Surg, 2019,228(6):831-838.
[15] Kakuta T, Sawada K, Kanai G, et al. Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hy-perparathyroidism[J]. Sci Rep, 2020,10(1):3290.
